Despite Progress, Mortality Still Risk Up in Patients With T2DM

Share this content:
Despite Progress, Mortality Still Risk Up in Patients With T2DM
Despite Progress, Mortality Still Risk Up in Patients With T2DM

THURSDAY, Oct. 29, 2015 (HealthDay News) -- Type 2 diabetes still substantially increases mortality risk, with the degree of risk varying with age, renal complications, and glycemic control, according to research published in the Oct. 29 issue of the New England Journal of Medicine.

The new study used data from the Swedish National Diabetes Register to compare the mortality rate among 435,369 people with type 2 diabetes with that of a healthy control group of 2.1 million people. The researchers found that excess risk of death was two to three times higher among those younger than 55, compared to between 30 and 40 percent higher for patients aged 65 to 75.

Patients younger than 55 who've entered end-stage renal disease are 14 times more likely to die than a healthy person. End-stage renal disease also multiplies the mortality risk seven-fold for those 55 to 64, and six-fold for those 65 to 74, the investigators found.

Anyone who didn't manage their diabetes through lifestyle changes, insulin, or medication faced a greatly increased risk of death, said study coauthor Mikhail Kosiborod, M.D. Kosiborod is a cardiologist at Saint Luke's Mid America Heart Institute and a professor of medicine at the University of Missouri-Kansas City. "If you look at the data, regardless of the age we look at, regardless of everything else, the worse the glycemic control the higher the mortality," he told HealthDay.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »